Atlas Trials

Expanded Access to TAK-881 for People With Primary Immunodeficiency Diseases in the USA and Czech Republic

Clinical trial NCT06955793 · AVAILABLE

Trial details

NCT number
NCT06955793
Sponsor
Takeda
Status
AVAILABLE
Study type
EXPANDED_ACCESS
Primary Immunodeficiency Diseases (PIDD)

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.